Ionis Pharmaceuticals (IONS) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -657.1 | -20.8 | -27.0 | -12.3 | -43.9 | 2.78 | ||
| Changes by years, y/y, % | +950% | -97% | +30% | -54% | +258% | -6.8% | |||
Ionis Pharmaceuticals. EV/EBITDA
Ionis Pharmaceuticals. EV/EBITDA, changes, %
Ionis Pharmaceuticals (IONS) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -12.9 | -32.3 | -63.6 | 2.81 | 2.76 | 2.78 | |
| Changes by years, y/y, % | -44% | +26% | +221% | -121% | -121% | |||
| Changes by quarters, q/q, % | -2% | +150% | +97% | -104% | -2% | |||